Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Armored CAR T cells enhance antitumor efficacy and overcome the tumor microenvironment
Oladapo O. Yeku, Terence J. Purdon, Mythili Koneru, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 341

Showing 1-25 of 341 citing articles:

A guide to cancer immunotherapy: from T cell basic science to clinical practice
Alex D. Waldman, Jill M. Fritz, Michael J. Lenardo
Nature reviews. Immunology (2020) Vol. 20, Iss. 11, pp. 651-668
Open Access | Times Cited: 3206
Engineering strategies to overcome the current roadblocks in CAR T cell therapy
Sarwish Rafiq, Christopher S. Hackett, Renier J. Brentjens
Nature Reviews Clinical Oncology (2019) Vol. 17, Iss. 3, pp. 147-167
Open Access | Times Cited: 1123
Mechanisms of resistance to CAR T cell therapy
Nirali N. Shah, Terry J. Fry
Nature Reviews Clinical Oncology (2019)
Open Access | Times Cited: 836
CAR T Cells for Solid Tumors: New Strategies for Finding, Infiltrating, and Surviving in the Tumor Microenvironment
Marina C. Martinez, Edmund K. Moon
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 732
Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo
Sarwish Rafiq, Oladapo O. Yeku, Hollie J. Jackson, et al.
Nature Biotechnology (2018) Vol. 36, Iss. 9, pp. 847-856
Open Access | Times Cited: 678
Recent advances and discoveries in the mechanisms and functions of CAR T cells
Rebecca C. Larson, Marcela V. Maus
Nature reviews. Cancer (2021) Vol. 21, Iss. 3, pp. 145-161
Open Access | Times Cited: 634
Engineering CAR-T Cells for Next-Generation Cancer Therapy
Mihe Hong, Justin Clubb, Yvonne Y. Chen
Cancer Cell (2020) Vol. 38, Iss. 4, pp. 473-488
Open Access | Times Cited: 484
Teaching an old dog new tricks: next-generation CAR T cells
Nicholas Tokarew, Justyna Ogonek, Stefan Endres, et al.
British Journal of Cancer (2018) Vol. 120, Iss. 1, pp. 26-37
Open Access | Times Cited: 347
T Cell Dysfunction and Exhaustion in Cancer
Zhen Zhang, Shasha Liu, Bin Zhang, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 304
Recent advances in CAR-T cell engineering
Ruihao Huang, Xiaoping Li, Yundi He, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 297
Trial watch: Immunogenic cell death induction by anticancer chemotherapeutics
Abhishek D. Garg, Sanket More, Nicole Rufo, et al.
OncoImmunology (2017) Vol. 6, Iss. 12, pp. e1386829-e1386829
Open Access | Times Cited: 241
CAR-T Cells Hit the Tumor Microenvironment: Strategies to Overcome Tumor Escape
Alba Rodríguez-García, Asís Palazón, Estela Noguera-Ortega, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 240
Improving CAR-T immunotherapy: Overcoming the challenges of T cell exhaustion
Diana Gumber, Leo D. Wang
EBioMedicine (2022) Vol. 77, pp. 103941-103941
Open Access | Times Cited: 229
Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: clinical perspective and significance
Michael Boyiadzis, Madhav V. Dhodapkar, Renier J. Brentjens, et al.
Journal for ImmunoTherapy of Cancer (2018) Vol. 6, Iss. 1
Open Access | Times Cited: 222
Intratumoral IL-12 delivery empowers CAR-T cell immunotherapy in a pre-clinical model of glioblastoma
Giulia Agliardi, Anna Rita Liuzzi, Alastair Hotblack, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 211
IFN-γ: A cytokine at the right time, is in the right place
J. D. Burke, Howard A. Young
Seminars in Immunology (2019) Vol. 43, pp. 101280-101280
Open Access | Times Cited: 204
Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology
Isaure Vanmeerbeek, Jenny Sprooten, Dirk De Ruysscher, et al.
OncoImmunology (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 194
CD40 Ligand-Modified Chimeric Antigen Receptor T Cells Enhance Antitumor Function by Eliciting an Endogenous Antitumor Response
Nicholas F. Kuhn, Terence J. Purdon, Dayenne G. van Leeuwen, et al.
Cancer Cell (2019) Vol. 35, Iss. 3, pp. 473-488.e6
Open Access | Times Cited: 192
A cross-talk between CAR T cell subsets and the tumor microenvironment is essential for sustained cytotoxic activity
Morgane Boulch, Marine Cazaux, Yann Loe-Mie, et al.
Science Immunology (2021) Vol. 6, Iss. 57
Open Access | Times Cited: 155
Multi Targeted CAR-T Cell Therapies for B-Cell Malignancies
Nirav N. Shah, Theresa Maatman, Parameswaran Hari, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 154
Limitations in the Design of Chimeric Antigen Receptors for Cancer Therapy
Stefan Stoiber, Bruno L. Cadilha, Mohamed-Reda Benmebarek, et al.
Cells (2019) Vol. 8, Iss. 5, pp. 472-472
Open Access | Times Cited: 153
A genome-scale screen for synthetic drivers of T cell proliferation
Mateusz Legut, Zoran Gajic, Maria Guarino, et al.
Nature (2022) Vol. 603, Iss. 7902, pp. 728-735
Open Access | Times Cited: 137
Pembrolizumab for B-cell lymphomas relapsing after or refractory to CD19-directed CAR T-cell therapy
Elise A. Chong, Cécile Alanio, Jakub Svoboda, et al.
Blood (2021) Vol. 139, Iss. 7, pp. 1026-1038
Open Access | Times Cited: 122
CAR T-cell therapy for multiple myeloma: state of the art and prospects
Niels W.C.J. van de Donk, Saad Z. Usmani, Kwee Yong
The Lancet Haematology (2021) Vol. 8, Iss. 6, pp. e446-e461
Closed Access | Times Cited: 120
Engineering cytokine therapeutics
Jeroen Deckers, Tom Anbergen, Ayla M. Hokke, et al.
Nature Reviews Bioengineering (2023) Vol. 1, Iss. 4, pp. 286-303
Open Access | Times Cited: 119
Page 1 - Next Page

Scroll to top